Drugs / HU-014
HU-014
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04415346 | Nov 2019 → Jun 2020 | diplegia of upper limb | Huons Co., Ltd. | Unknown | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02961673 | Sep 2016 → Feb 2017 | — | Huons Co., Ltd. | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT05289921 | Mar 2022 → Jan 2023 | — | Huons Co., Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT04081402 | Nov 2018 → Nov 2019 | — | Huons Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HU-014 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05289921 ↗ |
| Known as | HUTOX | “A Phase 1/3 Clinical Trial to Evaluate the Safety and Efficacy of HUTOX Compared to Botox® in Subjects With Moderate to Severe Crow's Feet Lines” NCT04081402 ↗ |
| Known as | Hutox Inj | “Hutox Inj(Clostridium botulinum type A)” NCT04081402 ↗ |
| Known as | LIZTOX | “Investigational Product: LIZTOX inj 100unit(HU-014)” NCT04415346 ↗ |
| Known as | LIZTOX inj | “Investigational Product: LIZTOX inj 100unit(HU-014)” NCT05289921 ↗ |
| Route | Intramuscular | “HU-014 Inj was given an injection to 5 Upper limb muscle(Total 360U/, IM)” NCT04415346 ↗ |